Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FBXO21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYO3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASL10B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEX261 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD87 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CENPBD1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928973 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUNDC3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on